27 studies found for:
Quercetin
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD)
|
||||
| 2 | Recruiting |
Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
|
||||
| 3 | Completed |
Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)
|
||||
| 4 | Completed |
Effect of Quercetin in Prevention and Treatment of Oral Mucositis
|
||||
| 5 | Completed |
Effect of Combined Exercise, Heat, and Quercetin Supplementation on Whole Body Stress Response
|
||||
| 6 | Recruiting |
Prostate Cancer Prevention Trial With Quercetin and Genistein
|
||||
| 7 | Recruiting |
Quercetin PK/PD Study in Healthy Adults
|
||||
| 8 | Completed |
The Effect of Quercetin in Sarcoidosis
|
||||
| 9 | Recruiting |
Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus
|
||||
| 10 | Recruiting |
Quercetin in Children With Fanconi Anemia; a Pilot Study
|
||||
| 11 | Recruiting |
Q-Trial in Patients With Hepatitis C
|
||||
| 12 | Completed |
Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators
|
||||
| 13 | Active, not recruiting |
Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement
|
||||
| 14 | Completed |
Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH)
|
||||
| 15 | Completed |
Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders
|
||||
| 16 | Terminated |
Sulindac and Plant Compounds in Preventing Colon Cancer
|
||||
| 17 | Unknown † |
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
|
||||
| 18 | Unknown † |
Dietary Intervention in Follicular Lymphoma
|
||||
| 19 | Recruiting |
Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes
|
||||
| 20 | Recruiting |
Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease
|
† Indicates status has not been verified in more than two years
